Herpes Simplex Virus-2 Genital Tract Shedding Is Not Predictable over Months or Years in Infected Persons

PLoS Computational Biology

Volumn 10, Issue 11, 2014, Pages

  Dhankani, Varsha ^a   Kutz, J Nathan ^a   Schiffer, Joshua T ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISCRIMINANT ANALYSIS; SINGULAR VALUE DECOMPOSITION; STOCHASTIC MODELS; STOCHASTIC SYSTEMS; TIME SERIES; TIME SERIES ANALYSIS; VIRUSES;

CELL DENSITY; COMPLEX MORPHOLOGY; DATA OUTPUT; HERPES SIMPLEX VIRUS 2; IMMUNE CELLS; PRINCIPAL-COMPONENT ANALYSIS; SIMULATION OUTPUTS; STOCHASTICS; TIME-SERIES DATA; TIME-SERIES SIMULATION;

PRINCIPAL COMPONENT ANALYSIS;

ANALYTICAL PARAMETERS; ARTICLE; CD8+ T LYMPHOCYTE; CELL DENSITY; DISCRIMINANT ANALYSIS; GENETIC HETEROGENEITY; GENITAL TRACT INFECTION; HERPES SIMPLEX VIRUS 2; IMMUNOCOMPETENT CELL; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; MORPHOLOGY; NONHUMAN; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; SIMULATION; SINGULAR VALUE DECOMPOSITION; STATISTICAL MODEL; SUPPORT VECTOR MACHINE; VIRUS REACTIVATION; VIRUS SHEDDING; BIOLOGICAL MODEL; BIOLOGY; GENITAL HERPES; HOST PATHOGEN INTERACTION; HUMAN; PHYSIOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 2;

COMPUTATIONAL BIOLOGY; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; PRINCIPAL COMPONENT ANALYSIS; VIRUS SHEDDING;

EID: 84912117871     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003922     Document Type: Article

References (30)

1. Perelson A, Neumann A, Markowitz M, Leonard J, Ho D, (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582–1586.
2. Shen L, Rabi SA, Sedaghat AR, Shan L, Lai J, et al. (2011) A Critical Subset Model Provides a Conceptual Basis for the High Antiviral Activity of Major HIV Drugs. Sci Transl Med 3: 91ra63.
3. Schiffer JT, Swan DA, Corey L, Wald A, (2013) Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents. Antimicrob Agents Chemother 57: 5820–5829.
4. Rong L, Perelson AS, (2009) Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy. PLoS Comput Biol 5: e1000533.
5. Wald A, Zeh J, Selke S, Warren T, Ryncarz A, et al. (2000) Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342: 844–850.
6. Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, et al. (2009) Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model. Sci Transl Med 1: 7ra16.
7. Schiffer JT, Magaret A, Selke S, Corey L, Wald A, (2011) Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy. J Antimicrob Chemother 66: 2593–2600.
8. Schiffer JT, Swan D, Al Sallaq R, Magaret A, Johnston C, et al. (2013) Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract. Elife 2: e00288.
9. Schiffer JT, (2013) Mucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future Protection. Front Immunol 4: 209.
10. May RM, (2004) Uses and abuses of mathematics in biology. Science 303: 790–793.
11. Chen Y, Xu XH, (2014) Supervised orthogonal discriminant subspace projects learning for face recognition. Neural Netw 50: 33–46.
12. David CC, Jacobs DJ, (2014) Principal component analysis: a method for determining the essential dynamics of proteins. Methods Mol Biol 1084: 193–226.
13. Schiffer JT, Wald A, Selke S, Corey L, Magaret A, (2011) The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions. J Infect Dis 204: 554–561.
14. Mark KE, Wald A, Magaret AS, Selke S, Olin L, et al. (2008) Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 198: 1141–1149.
15. Blank H, Haines HG, (1973) Experimental human reinfection with herpes simplex virus. J Invest Dermatol 61: 223–225.
16. Corey L, Adams HG, Brown ZA, Holmes KK, (1983) Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 98: 958–972.
17. Zhu J, Koelle D, Cao J, Vazquez J, Huang M, et al. (2007) Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 204: 595–603.
18. Zhu J, Hladik F, Woodward A, Klock A, Peng T, et al. (2009) Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 15: 886–892.
19. Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, et al. (2010) Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes. Proc Natl Acad Sci U S A 107: 18973–18978.
20. Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, et al. (2009) Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 10: 524–530.
21. Shin H, Iwasaki A, (2012) A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491: 463–467.
22. Rosentsein MT, Collins JC, De Luca CJ, (1993) A practical method for calculating largest Lyapunov exponents from small data sets. Physica D 65: 117–34.
23. Lorenz EN, (1963) Deterministic nonperiodic flow. Journal of the Atmospheric Sciences 20: 130–141.
24. Wald A, Zeh J, Selke S, Ashley RL, Corey L, (1995) Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333: 770–775.
25. Mertz GJ, Coombs RW, Ashley R, Jourden J, Remington M, et al. (1988) Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 157: 1169–1177.
26. Phipps W, Saracino M, Magaret A, Selke S, Remington M, et al. (2011) Persistent genital herpes simplex virus-2 shedding years following the first clinical episode. J Infect Dis 203: 180–187.
27. Maia PD, Kutz JN, (2013) Identifying critical regions for spike propagation in axon segments. J Comput Neurosci
28. Strachan E, Saracino M, Selke S, Magaret A, Buchwald D, et al. (2011) The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women. Brain Behav Immun 25: 1475–1481.
29. Koelle DM, Magaret A, Warren T, Schellenberg GD, Wald A, (2010) APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding. Sex Transm Infect 86: 202–206.
30. Posavad C, Wald A, Kuntz S, Huang M, Selke S, et al. (2004) Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. J Infect Dis 190: 693–696.